Insider · CIK 0001338185
Davis Thomas Andrew
Reports to the SEC for 3 companies · CLARKSVILLE, MD
Transactions
27
Companies
3
Filings
13
CIK
0001338185
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-04-04 | GENOCEA BIOSCIENCES, INC.S Sale | −$1,363.75 |
| 2022-03-16 | GENOCEA BIOSCIENCES, INC.S Sale | −$2,988.7 |
| 2022-03-15 | GENOCEA BIOSCIENCES, INC.A Award | — |
| 2022-03-15 | GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2021-06-01 | GENOCEA BIOSCIENCES, INC.S Sale | −$1,168.52 |
| 2021-04-02 | GENOCEA BIOSCIENCES, INC.S Sale | −$2,569.08 |
| 2021-03-15 | GENOCEA BIOSCIENCES, INC.A Award | — |
| 2021-03-15 | GENOCEA BIOSCIENCES, INC.Restricted Stock UnitA Award | — |
| 2021-03-15 | GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2020-06-01 | GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2020-06-01 | GENOCEA BIOSCIENCES, INC.A Award | — |
| 2020-04-02 | GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2020-04-02 | GENOCEA BIOSCIENCES, INC.A Award | — |
| 2019-02-07 | GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2018-10-01 | GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award | — |
| 2017-06-15 | CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award | — |
| 2016-06-08 | CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award | — |
| 2015-06-10 | CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award | — |
| 2013-07-01 | CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award | — |
| 2012-09-12 | CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award | — |
| 2011-08-05 | CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award | +$293K |
| 2010-09-16 | CLDXCelldex Therapeutics, Inc.P Purchase | +$3,821.58 |
| 2010-09-16 | CLDXCelldex Therapeutics, Inc.P Purchase | +$5,613.53 |
| 2010-01-21 | CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award | +$428K |
| 2009-01-06 | CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award | +$651K |
| 2009-01-06 | CLDXCelldex Therapeutics, Inc.A Award | — |
| 2005-11-22 | GENVEC INCP Purchase | +$9,100 |
Recent filings
- 4Davis Thomas Andrew0001457612-22-000044SEC(opens sec.gov)
- 4Davis Thomas Andrew0001457612-22-000028SEC(opens sec.gov)
- 5Davis Thomas Andrew0001457612-22-000018SEC(opens sec.gov)
- 4Davis Thomas Andrew0001457612-21-000034SEC(opens sec.gov)
- 4Davis Thomas Andrew0001457612-20-000082SEC(opens sec.gov)
- 4Davis Thomas Andrew0001457612-20-000031SEC(opens sec.gov)
- 4Davis Thomas Andrew0001457612-19-000016SEC(opens sec.gov)
- 4Davis Thomas Andrew0001457612-18-000101SEC(opens sec.gov)
- 4Celldex Therapeutics, Inc.0001179110-17-009155SEC(opens sec.gov)
- 4Celldex Therapeutics, Inc.0001179110-16-026304SEC(opens sec.gov)
- 4Celldex Therapeutics, Inc.0001179110-15-009610SEC(opens sec.gov)
- 4Celldex Therapeutics, Inc.0001179110-13-011400SEC(opens sec.gov)
- 4Davis Thomas Andrew0001179110-12-013996SEC(opens sec.gov)
Companies
Address
6275 FIRETHON LANE
CLARKSVILLE, MD, 21029